Ken Cacciatore
Stock Analyst at TD Cowen
(0.30)
# 4,040
Out of 4,711 analysts
14
Total ratings
25%
Success rate
-30.5%
Average return
Main Sectors:
Stocks Rated by Ken Cacciatore
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics | Maintains: Outperform | $65 → $50 | $14.99 | +233.56% | 2 | Aug 9, 2023 | |
| BHC Bausch Health Companies | Downgrades: Market Perform | n/a | $7.47 | - | 1 | Jun 16, 2023 | |
| TAK Takeda Pharmaceutical | Maintains: Outperform | $30 → $20 | $13.10 | +52.67% | 4 | May 16, 2023 | |
| SCPH scPharmaceuticals | Initiates: Outperform | $25 | $3.39 | +637.46% | 1 | Dec 1, 2022 | |
| BLCO Bausch + Lomb | Initiates: Outperform | $35 | $18.00 | +94.44% | 1 | May 11, 2022 | |
| MOLN Molecular Partners AG | Initiates: Outperform | $50 | $5.08 | +884.25% | 1 | Jul 13, 2021 | |
| TARA Protara Therapeutics | Initiates: Outperform | $50 | $5.39 | +827.64% | 1 | Oct 19, 2020 | |
| BHVN Biohaven | Initiates: Outperform | $45 | $36.26 | +24.10% | 1 | Apr 17, 2020 | |
| AMRN Amarin Corporation | Initiates: Outperform | $23 | $0.46 | +4,900.00% | 1 | Mar 2, 2020 | |
| OPTN OptiNose | Initiates: Outperform | $25 | $0.42 | +5,850.96% | 1 | Dec 18, 2019 |
Arcutis Biotherapeutics
Aug 9, 2023
Maintains: Outperform
Price Target: $65 → $50
Current: $14.99
Upside: +233.56%
Bausch Health Companies
Jun 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.47
Upside: -
Takeda Pharmaceutical
May 16, 2023
Maintains: Outperform
Price Target: $30 → $20
Current: $13.10
Upside: +52.67%
scPharmaceuticals
Dec 1, 2022
Initiates: Outperform
Price Target: $25
Current: $3.39
Upside: +637.46%
Bausch + Lomb
May 11, 2022
Initiates: Outperform
Price Target: $35
Current: $18.00
Upside: +94.44%
Molecular Partners AG
Jul 13, 2021
Initiates: Outperform
Price Target: $50
Current: $5.08
Upside: +884.25%
Protara Therapeutics
Oct 19, 2020
Initiates: Outperform
Price Target: $50
Current: $5.39
Upside: +827.64%
Biohaven
Apr 17, 2020
Initiates: Outperform
Price Target: $45
Current: $36.26
Upside: +24.10%
Amarin Corporation
Mar 2, 2020
Initiates: Outperform
Price Target: $23
Current: $0.46
Upside: +4,900.00%
OptiNose
Dec 18, 2019
Initiates: Outperform
Price Target: $25
Current: $0.42
Upside: +5,850.96%